vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and GENCOR INDUSTRIES INC (GENC). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $23.6M, roughly 1.7× GENCOR INDUSTRIES INC). CODEXIS, INC. runs the higher net margin — 24.7% vs 14.6%, a 10.1% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -25.0%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $10.1M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -23.9%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.

CDXS vs GENC — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.7× larger
CDXS
$38.9M
$23.6M
GENC
Growing faster (revenue YoY)
CDXS
CDXS
+106.3% gap
CDXS
81.3%
-25.0%
GENC
Higher net margin
CDXS
CDXS
10.1% more per $
CDXS
24.7%
14.6%
GENC
More free cash flow
CDXS
CDXS
$9.4M more FCF
CDXS
$19.6M
$10.1M
GENC
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-23.9%
GENC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CDXS
CDXS
GENC
GENC
Revenue
$38.9M
$23.6M
Net Profit
$9.6M
$3.4M
Gross Margin
94.8%
28.7%
Operating Margin
27.1%
13.2%
Net Margin
24.7%
14.6%
Revenue YoY
81.3%
-25.0%
Net Profit YoY
192.5%
-9.8%
EPS (diluted)
$0.13
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
GENC
GENC
Q4 25
$38.9M
$23.6M
Q3 25
$8.6M
$18.8M
Q2 25
$15.3M
$27.0M
Q1 25
$7.5M
$38.2M
Q4 24
$21.5M
$31.4M
Q3 24
$12.8M
$20.9M
Q2 24
$8.0M
$25.6M
Q1 24
$17.1M
$40.7M
Net Profit
CDXS
CDXS
GENC
GENC
Q4 25
$9.6M
$3.4M
Q3 25
$-19.6M
$1.9M
Q2 25
$-13.3M
$3.8M
Q1 25
$-20.7M
$6.1M
Q4 24
$-10.4M
$3.8M
Q3 24
$-20.6M
$1.5M
Q2 24
$-22.8M
$2.6M
Q1 24
$-11.5M
$6.2M
Gross Margin
CDXS
CDXS
GENC
GENC
Q4 25
94.8%
28.7%
Q3 25
71.3%
24.2%
Q2 25
86.3%
26.5%
Q1 25
63.8%
29.7%
Q4 24
83.0%
27.6%
Q3 24
66.4%
25.6%
Q2 24
56.6%
23.9%
Q1 24
71.6%
30.3%
Operating Margin
CDXS
CDXS
GENC
GENC
Q4 25
27.1%
13.2%
Q3 25
-220.3%
-1.2%
Q2 25
-83.9%
11.6%
Q1 25
-271.6%
17.0%
Q4 24
-34.2%
14.7%
Q3 24
-129.0%
5.9%
Q2 24
-284.9%
7.8%
Q1 24
-69.6%
17.4%
Net Margin
CDXS
CDXS
GENC
GENC
Q4 25
24.7%
14.6%
Q3 25
-228.1%
10.2%
Q2 25
-86.6%
14.2%
Q1 25
-274.3%
16.0%
Q4 24
-48.4%
12.1%
Q3 24
-160.8%
6.9%
Q2 24
-285.2%
10.0%
Q1 24
-67.4%
15.3%
EPS (diluted)
CDXS
CDXS
GENC
GENC
Q4 25
$0.13
$0.23
Q3 25
$-0.22
$0.13
Q2 25
$-0.16
$0.26
Q1 25
$-0.25
$0.42
Q4 24
$-0.12
$0.26
Q3 24
$-0.29
$0.10
Q2 24
$-0.32
$0.17
Q1 24
$-0.16
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
GENC
GENC
Cash + ST InvestmentsLiquidity on hand
$78.2M
$147.7M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$215.2M
Total Assets
$147.8M
$228.9M
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
GENC
GENC
Q4 25
$78.2M
$147.7M
Q3 25
$58.7M
$136.3M
Q2 25
$66.3M
$136.0M
Q1 25
$59.8M
$143.7M
Q4 24
$73.5M
$130.1M
Q3 24
$90.3M
$115.4M
Q2 24
$73.2M
$116.6M
Q1 24
$85.5M
$117.1M
Total Debt
CDXS
CDXS
GENC
GENC
Q4 25
$40.1M
Q3 25
$39.7M
$0
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
$0
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
GENC
GENC
Q4 25
$50.5M
$215.2M
Q3 25
$38.5M
$211.8M
Q2 25
$55.6M
$209.9M
Q1 25
$49.6M
$206.1M
Q4 24
$66.9M
$200.0M
Q3 24
$73.4M
$196.1M
Q2 24
$61.4M
$194.7M
Q1 24
$79.3M
$192.1M
Total Assets
CDXS
CDXS
GENC
GENC
Q4 25
$147.8M
$228.9M
Q3 25
$124.0M
$222.6M
Q2 25
$138.2M
$220.2M
Q1 25
$128.9M
$223.9M
Q4 24
$149.0M
$218.2M
Q3 24
$148.2M
$208.1M
Q2 24
$132.0M
$201.8M
Q1 24
$149.6M
$206.0M
Debt / Equity
CDXS
CDXS
GENC
GENC
Q4 25
0.79×
Q3 25
1.03×
0.00×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
0.00×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
GENC
GENC
Operating Cash FlowLast quarter
$20.1M
$11.1M
Free Cash FlowOCF − Capex
$19.6M
$10.1M
FCF MarginFCF / Revenue
50.3%
43.0%
Capex IntensityCapex / Revenue
1.3%
4.1%
Cash ConversionOCF / Net Profit
2.09×
3.23×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$-3.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
GENC
GENC
Q4 25
$20.1M
$11.1M
Q3 25
$-7.7M
$-275.0K
Q2 25
$-18.0M
$-23.9M
Q1 25
$-13.8M
$12.4M
Q4 24
$-16.5M
$14.8M
Q3 24
$-13.0M
$-3.2M
Q2 24
$-12.2M
$-1.0M
Q1 24
$-7.8M
$11.7M
Free Cash Flow
CDXS
CDXS
GENC
GENC
Q4 25
$19.6M
$10.1M
Q3 25
$-7.9M
$-1.3M
Q2 25
$-20.5M
$-24.4M
Q1 25
$-15.1M
$12.3M
Q4 24
$-18.2M
$14.5M
Q3 24
$-14.0M
$-3.3M
Q2 24
$-12.6M
$-1.4M
Q1 24
$-8.9M
$11.7M
FCF Margin
CDXS
CDXS
GENC
GENC
Q4 25
50.3%
43.0%
Q3 25
-91.7%
-6.8%
Q2 25
-133.6%
-90.4%
Q1 25
-199.6%
32.2%
Q4 24
-85.0%
46.1%
Q3 24
-109.0%
-15.8%
Q2 24
-157.5%
-5.6%
Q1 24
-52.2%
28.7%
Capex Intensity
CDXS
CDXS
GENC
GENC
Q4 25
1.3%
4.1%
Q3 25
2.1%
5.4%
Q2 25
16.4%
1.8%
Q1 25
16.7%
0.4%
Q4 24
8.3%
1.0%
Q3 24
7.8%
0.4%
Q2 24
5.0%
1.5%
Q1 24
6.6%
0.0%
Cash Conversion
CDXS
CDXS
GENC
GENC
Q4 25
2.09×
3.23×
Q3 25
-0.14×
Q2 25
-6.24×
Q1 25
2.04×
Q4 24
3.88×
Q3 24
-2.22×
Q2 24
-0.41×
Q1 24
1.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons